For initial serology in children with suspected CeD, ESPGHAN recommends measuring only transglutaminase‐antibodies (TGA‐immunoglobulin A [IgA]) and total IgA, regardless of age. This evidence concerns the gene CD79A and cranioectodermal dysplasia.